Juvenile Spondyloarthritis Disease Activity Index Validation in Enthesitis-Related Arthritis and Juvenile Psoriatic Arthritis in a Prospective Clinical Trial Setting
These results validate JSpADA as a disease activity measure for children with ERA and jPsA in a prospective clinical trial setting.
Authors
- Hermine I. Brunner (ORCID: https://orcid.org/0000-0001-9478-2987)
- Erhard Quebe‐Fehling (ORCID: https://orcid.org/0000-0003-1507-9543)
- Pamela F. Weiss (ORCID: https://orcid.org/0000-0002-9724-0443)
- Luminita Pricop
- Nicolino Ruperto (ORCID: https://orcid.org/0000-0001-8407-7782)
- Christelle C Pieterse
- Alexis Shew
Institutions
- Novartis (Switzerland) (CH)
- Children's Hospital of Philadelphia (US)
- Istituto Giannina Gaslini (IT)
- Syneos Health (United States) (US)
- University of Cincinnati (US)
- University of Cincinnati Medical Center (US)
Publication Details
- Journal
- The Journal of Rheumatology
- Published
- 2025-09-15
- DOI
- https://doi.org/10.3899/jrheum.2025-0294
- Primary Topic
- Autoimmune and Inflammatory Disorders Research
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- Bristol-Myers Squibb
- Eli Lilly and Company
- Pfizer
- Novartis Pharmaceuticals Corporation